CLINICAL STUDY ON DIABETIC FOOT AND ITS MANAGEMENT WITH KATUPILA AND BLOOD LETTING

CLINICAL STUDY ON MADHUMEHAJANAYA VRANA (WSR TO DIABETIC FOOT)AND ITS MANAGMENT WITH KATUPILA/HUMARI(Securinega leucopyrus)AND RAKTAMOKSHANA(BLOOD LETTING)

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/09/004020

Enrollment

Registered

2013-09-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- MADUMEHAJANYA VRANA (DIABETIC ULCER)

Interventions

Intervention1: KATUPILA FRESH LEAF KALKA WITH TILL TAILA: KATUPILA Securinega leupyrus FRESH LEAF KALKA WITH TILL TAILA SUFFICIENT AMOUNT TO COVER THE ULCER FOR DAILY EXTERNAL DRESSING OF ULCER FOR TW

Eligibility

Inclusion criteria

Inclusion criteria: DIAGNOSED CASES OF DUSHTA VRANA WITH REFERENCE TO DIABETIC FOOT ULCER WITH TYPE I & TYPE II DIABETES MELLITUS. PATIENTS OF AGE GROUP OF 15- 85 YEARS OF EITHER SEX.

Exclusion criteria

Exclusion criteria: PAST HISTORY OF TUBERCULOSIS FOOT ULCERS OTHER THAN DIABETES MELLITUS MALIGNANCY UNCONTROLLED HYPERTENSION HEART DISEASES LIKE MI, CAD, IHD PREGNANCY AGE BELOW 15 AND ABOVE 85 YEARS. PATIENTS WITH AIDS & STD PATIENTS OF ANEMIA (HB%

Design outcomes

Primary

Measure	Time frame
DEBRIDEMENT OF ULCER AND ENHANCED HEALING. HELP TO INHIBIT THE GROWTH OF MICROORGANISMS PROVOKING HEALTHY GRANULATION.Timepoint: FIRST MONTH	—

Secondary

Measure	Time frame
BETTERMENT OF WOUND CONTRACTION AND THE COMPLETE WOUND HEALING WILL BE OBSERVED WITH MINOR OR NO SCAR ALONG WITH RE-PIGMENTATION OF THE NEW TISSUETimepoint: 2 MONTHS	—

Countries

India

Contacts

Public ContactDR T S DUDHAMAL

IPGT & RA GUJARAT AYURVED UNIVERSITY

sabinaurs@gmail.com9537404480

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026